Works matching DE "POLO-like kinases"


Results: 169
    1

    Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma.

    Published in:
    Liver International, 2015, v. 35, n. 11, p. 2448, doi. 10.1111/liv.12839
    By:
    • Juntermanns, Benjamin;
    • Sydor, Svenja;
    • Kaiser, Gernot M.;
    • Jaradat, Derar;
    • Mertens, Joachim C.;
    • Sotiropoulos, Georgios C.;
    • Swoboda, Sandra;
    • Neuhaus, Jan P.;
    • Meng, Wei;
    • Mathé, Zoltan;
    • Baba, Hideo A.;
    • Canbay, Ali;
    • Paul, Andreas;
    • Fingas, Christian D.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network

    Published in:
    British Journal of Cancer, 2012, v. 107, n. 2, p. 280, doi. 10.1038/bjc.2012.257
    By:
    • Mross, K;
    • Dittrich, C;
    • Aulitzky, W E;
    • Strumberg, D;
    • Schutte, J;
    • Schmid, R M;
    • Hollerbach, S;
    • Merger, M;
    • Munzert, G;
    • Fleischer, F;
    • Scheulen, M E
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    P53 suppresses SENP3 phosphorylation to mediate G2 checkpoint.

    Published in:
    Cell Discovery, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41421-020-0154-2
    By:
    • Wang, Yang;
    • Tian, Jing;
    • Huang, Chao;
    • Ma, Jiao;
    • Hu, Gaolei;
    • Chen, Yalan;
    • Wang, Tianshi;
    • Cai, Rong;
    • Zuo, Yong;
    • Tan, Hongsheng;
    • Fan, Qiuju;
    • Dong, Baijun;
    • Xue, Wei;
    • Yi, Jing;
    • Chen, Guoqiang;
    • Tu, Jun;
    • Cheng, Jinke
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23186-w
    By:
    • Carr, Ryan M.;
    • Vorobyev, Denis;
    • Lasho, Terra;
    • Marks, David L.;
    • Tolosa, Ezequiel J.;
    • Vedder, Alexis;
    • Almada, Luciana L.;
    • Yurcheko, Andrey;
    • Padioleau, Ismael;
    • Alver, Bonnie;
    • Coltro, Giacomo;
    • Binder, Moritz;
    • Safgren, Stephanie L.;
    • Horn, Isaac;
    • You, Xiaona;
    • Solary, Eric;
    • Balasis, Maria E.;
    • Berger, Kurt;
    • Hiebert, James;
    • Witzig, Thomas
    Publication type:
    Article
    27
    28
    29
    30
    31
    32

    PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas.

    Published in:
    2018
    By:
    • Yuan Ren;
    • Chengfeng Bi;
    • Xiaohong Zhao;
    • Tint Lwin;
    • Cheng Wang;
    • Ji Yuan;
    • Silva, Ariosto S.;
    • Shah, Bijal D.;
    • Fang, Bin;
    • Tao Li;
    • Koomen, John M.;
    • Huijuan Jiang;
    • Chavez, Julio C.;
    • Pham, Lan V.;
    • Sudalagunta, Praneeth R.;
    • Lixin Wan;
    • Xuefeng Wang;
    • Dalton, William S.;
    • Moscinski, Lynn C.;
    • Shain, Kenneth H.
    Publication type:
    journal article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Anticancer activity of a novel small molecule tubulin inhibitor STK899704.

    Published in:
    PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0173311
    By:
    • Sakchaisri, Krisada;
    • Kim, Sun-Ok;
    • Hwang, Joonsung;
    • Soung, Nak Kyun;
    • Lee, Kyung Ho;
    • Choi, Tae Woong;
    • Lee, Yongjun;
    • Park, Chan-Mi;
    • Thimmegowda, Naraganahalli R.;
    • Lee, Phil Young;
    • Shwetha, Bettaswamigowda;
    • Srinivasrao, Ganipisetti;
    • Pham, Thi Thu Huong;
    • Jang, Jae-Hyuk;
    • Yum, Hye-Won;
    • Surh, Young-Joon;
    • Lee, Kyung S.;
    • Park, Hwangseo;
    • Kim, Seung Jun;
    • Kwon, Yong Tae
    Publication type:
    Article
    47
    48
    49
    50